Diversify Wealth Management LLC Cuts Stake in Humana Inc. (NYSE:HUM)

Diversify Wealth Management LLC cut its holdings in Humana Inc. (NYSE:HUM) by 28.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,010 shares of the insurance provider’s stock after selling 396 shares during the period. Diversify Wealth Management LLC’s holdings in Humana were worth $320,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Swedbank AB lifted its holdings in shares of Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after buying an additional 3,085 shares in the last quarter. Heritage Oak Wealth Advisors LLC purchased a new stake in Humana in the 2nd quarter worth $3,456,000. Mandatum Life Insurance Co Ltd boosted its holdings in shares of Humana by 115.4% during the 3rd quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock valued at $4,434,000 after purchasing an additional 7,500 shares during the last quarter. APG Asset Management US Inc. grew its position in shares of Humana by 3.0% during the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock valued at $25,274,000 after purchasing an additional 1,955 shares in the last quarter. Finally, Sei Investments Co. increased its holdings in shares of Humana by 0.4% in the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after purchasing an additional 264 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

Humana stock opened at $260.71 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.66. The stock has a market cap of $31.39 billion, a price-to-earnings ratio of 23.09, a price-to-earnings-growth ratio of 2.07 and a beta of 0.50. The firm has a 50-day moving average of $297.06 and a two-hundred day moving average of $334.38. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $527.18.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, research analysts forecast that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.

Analysts Set New Price Targets

A number of brokerages recently commented on HUM. JPMorgan Chase & Co. increased their price target on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Stephens restated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research report on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Finally, Truist Financial reduced their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $315.48.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.